Ms Barbara K Henry, LCSW in Kiel, WI - Social Worker

Ms Barbara K Henry, LCSW is a Social Worker - Clinical based in Kiel, Wisconsin. Ms Barbara K Henry is licensed to practice in Wisconsin (license number 506-123) and her current practice location is 317 Fremont St, Kiel, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (920) 894-7900.

NPI number for Ms Barbara K Henry is 1487761094 and her current mailing address is Po Box 305, Kiel, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1487761094.

Contact Information

	Ms Barbara K Henry, LCSW
	317 Fremont St, Kiel, WI 53042-1423
	(920) 894-7900
	(920) 894-7900

Healthcare Provider's Profile

Full Name	Ms Barbara K Henry
Gender	Female
Speciality	Social Worker - Clinical
Location	317 Fremont St, Kiel, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1487761094
Provider Enumeration Date: 08/23/2006
Last Update Date: 10/27/2011

Medical Identifiers

Medical identifiers for Ms Barbara K Henry such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1487761094	NPI	-	NPPES
39254200	Medicaid	WI

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	506-123 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Barbara K Henry is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Barbara K Henry, LCSW Po Box 305, Kiel, WI 53042-0305 Ph: (920) 894-7900	Ms Barbara K Henry, LCSW 317 Fremont St, Kiel, WI 53042-1423 Ph: (920) 894-7900

News Archive

Study finds no evidence that testosterone replacement therapy increases cardiovascular risk

Fears of a link between testosterone replacement therapy and cardiovascular risk are misplaced, according to a review published in this month's Mayo Clinic Proceedings. The therapy has come under widespread scrutiny in recent months, including by a federal Food and Drug Administration panel convened last fall.

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.

Kaiser denies Prime Healthcare claims over purchase of Daughters of Charity Health System

In a bizarre announcement, Prime Healthcare said Monday that Kaiser Permanente was now supporting its purchase of Daughters of Charity Health System, a claim that Kaiser has unequivocally denied.

Moffitt study may lead to potential treatment options for cutaneous T cell lymphoma

Cutaneous T cell lymphomas (CTCLs) are a group of non-Hodgkin lymphomas that develop from T cells and mainly impact the skin with painful lesions.

Research shows link between higher generic drug use and Medicare Part D star ratings

Value in Health, the official journal of ISPOR, announced today the publication of new research showing that Medicare Part D prescription plans with higher generic drug use have higher summary star ratings and improved member experience.

Ms Barbara K Henry, LCSW - Clinical Social Worker in Kiel, WI